AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 JUL 4 - (NewsRx.com & NewsRx.net) --
pAllliance, a strategic alliance between QIAGEN N.V. (Nasdaq: QGENF; Neuer Markt: QIA; Easdaq: QGEN), DSM Biologics, Valentis Inc. (Nasdaq: VLTS), and the Wyeth-Lederle Vaccines (WLV), a business unit of the American Home Products Corporation (NYSE: AHP), announced an agreement pursuant to which the pAlliance will manufacture plasmid DNA-based vaccine materials for WLV's clinical trials.
The pAlliance members believe that this agreement represents one of the largest agreements for pAlliance since the it was initiated in early 1999 and started supplying contract manufacturing services for DNA-based therapeutics and vaccines to what is today a significant group of customers in the pharmaceutical and biotech industries.
"We believe ...
Source: HighBeam Research, Manufacturing Agreement Reached For Plasmid DNA-Based Vaccine.(Brief...